News tagged with merck

Faulty gene connected to ovarian cancer risk

In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault and tests are expect ...

Aug 09, 2011
popularity not rated yet | comments 0 | with audio podcast report

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

May 21, 2013
popularity 4.2 / 5 (5) | comments 0

Cervical cancer vaccine shows promise

A vaccine against cervical cancer, being developed by Inovio Pharmaceuticals Inc. of Blue Bell, Pa., produced positive results in a small sample of 18 women.

Oct 12, 2012
popularity 5 / 5 (3) | comments 0

Merck blood thinner shows mixed results: study

An experimental blood thinning drug made by the pharmaceutical giant Merck may reduce the risk of dying from a heart attack but also boosts the danger of internal bleeding, researchers said Saturday.

Mar 24, 2012
popularity not rated yet | comments 0

FDA approves first diabetes-cholesterol combo pill

(AP) -- The first combination pill for the millions of people with the dangerous combination of diabetes and high cholesterol won U.S. approval Friday, offering convenience - and savings - to patients taking multiple pills.

Oct 07, 2011
popularity not rated yet | comments 0

Older pills often safer; many think new is better

Many consumers mistakenly believe new prescription drugs are always safer than those with long track records, and that only extremely effective drugs without major side effects win government approval, according to a new ...

Sep 12, 2011
popularity 3 / 5 (3) | comments 0

Merck: New drugs pending approval or in late tests

Merck & Co. could get an impressive six new prescription medicines approved in the U.S. this year and will soon apply for regulatory approval of two others, company executives said Tuesday during a briefing on Merck's business.

May 06, 2014
popularity 5 / 5 (1) | comments 0